The Oxford University genetic sequencing spinout is reportedly mulling an IPO that would provide exits to investors including commercialisation firm IP Group.
Oxford Nanopore Technologies, a UK-based genetic sequencing technology developer spun out from University of Oxford, is considering floating its shares in an initial public offering (IPO), The Telegraph has reported.
Founded in 2005, Oxford Nanopore has developed real-time DNA and RNA sequencing technology that offers biological analyses at a relatively low cost. It has applications in disease and pathogen surveillance, environmental monitoring, food supply chain inspection and microgravity biology.
The company markets portable, desktop and large-scale models of…
